Accessibility StatementSkip Navigation LEBANON, Tenn., Oct. 2, 2025 /PRNewswire/ --Â Cracker Barrel Old Country Store, Inc. ("Cracker Barrel") today announced leadership and organizational structure enhancements as the Company reinforces its focus on delivering outstanding food and experiences guests love."These changes to our organizational structure, along with new leadership appointments and promotions, mark a strategic step forward as we sharpen our focus on consistently craveable food and warm country ...

Financial Data and Key Metrics Changes - Second quarter revenue was approximately flat at $48.9 million, reflecting an 8.4% decrease in procedure revenue, partially offset by over 30% sales growth in dietary supplements [13][14] - Gross profit margin improved to 71.6%, a 280 basis point increase, primarily due to cost savings from vertical integration [14] - Selling, general and administrative expenses decreased by 12.2% to $24.2 million, influenced by the timing of the annual marketing event and headcount adjustments [15] - Net income was $3.9 million, compared to a net loss of $10.4 million in the previous year, with diluted earnings per share of $0.10 [15][16] - Adjusted EBITDA increased by 19.1% to $15.2 million, with an adjusted EBITDA margin of 31.1% [16] Business Line Data and Key Metrics Changes - Procedure revenue experienced an 8.4% decline, attributed to slower growth in new clinic additions, higher attrition rates, and lower procedure volumes [13][14] - Dietary supplement revenue increased by 30.4% to $10.7 million, driven primarily by growth in the e-commerce channel [14] Market Data and Key Metrics Changes - The company anticipates high single-digit declines in procedure revenue for the full year, while dietary supplement growth is expected at approximately mid-teens percentage rate [18] - The company is adjusting its fiscal 2025 revenue guidance to above $190 million, reflecting the impacts of ongoing organizational restructuring [18] Company Strategy and Development Direction - The company is undergoing a strategic organizational restructuring aimed at driving sustainable growth, focusing on three key objectives: accelerating new provider wins, strengthening relationships with existing practitioners, and improving financial performance [7][8] - New leadership has been brought in to enhance commercial productivity and instill a high-performance culture [9][10] - The company is focused on capturing a larger share of the hormone replacement therapy and therapeutic wellness markets [10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that the organizational changes have been disruptive, particularly affecting procedure-related sales, but expressed confidence in the long-term growth strategy [12][13] - The company is committed to excellence and aims to achieve a higher level of operational and financial performance despite the challenges faced in 2025 [20] Other Important Information - Cash flow from operations for the second quarter was $7.1 million, with cash and cash equivalents at $19.6 million as of June 30, 2025, down from $41.7 million at the end of the previous quarter [17] Q&A Session Summary Question: Progress on verticalization process - Management indicated that penetration is currently in the low 40% range and plans to resume efforts to increase this in Q3 [22][23] Question: Absolute number of procedures down in the quarter - Management noted that headwinds include clinic attrition and lower volumes within existing clinics, which have been ongoing since the launch of the clinical decision support software [25][26] Question: Factors needed for metrics to turn around - Management expressed optimism that recent changes will lead to improved metrics, but it is too early to predict specific outcomes [28][30] Question: Drivers of faster attrition - Management clarified that GLP-1s are not impacting procedure revenue and attributed the headwinds to the launch of the clinical decision support software and organizational changes [36][37] Question: Changes in new clinic additions - Management acknowledged a slowdown in new starts and emphasized the need for improved retention and new clinic additions to drive growth [42][43] Question: Changes in sales force and marketing - Management highlighted that restructuring has focused on growth targets and accountability, with a revamped compensation plan to incentivize growth [48][49]